{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:47:25Z","timestamp":1782182845672,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011193"],"award-info":[{"award-number":["2023J011193"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2024J08254"],"award-info":[{"award-number":["2024J08254"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Joint Fund Project for Science Research and Technology Innovation of Fujian Provincial Department of Science and Technology","award":["2024Y9038"],"award-info":[{"award-number":["2024Y9038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16083-2","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:16:43Z","timestamp":1777864603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PPP4C: a potential molecular marker and therapeutic target in thyroid cancer and triple-negative breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Huashui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"1","key":"16083_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"16083_CR2","doi-asserted-by":"publisher","first-page":"e071674","DOI":"10.1136\/bmj-2022-071674","volume":"381","author":"RA Leon-Ferre","year":"2023","unstructured":"Leon-Ferre RA, Goetz MP. Advances in systemic therapies for triple negative breast cancer. BMJ. 2023;381:e071674.","journal-title":"BMJ"},{"key":"16083_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of Triple-Negative Breast Cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"key":"16083_CR4","doi-asserted-by":"publisher","first-page":"1138149","DOI":"10.3389\/fendo.2023.1138149","volume":"14","author":"H Tan","year":"2023","unstructured":"Tan H, Wang S, Huang F, Tong Z. Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2023;14:1138149.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"16083_CR5","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/ijc.32988","volume":"147","author":"S Yuan","year":"2020","unstructured":"Yuan S, Kar S, Vithayathil M, Carter P, Mason AM, Burgess S, et al. Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two-sample Mendelian randomization study. Int J Cancer. 2020;147(7):1895\u2013903.","journal-title":"Int J Cancer"},{"key":"16083_CR6","doi-asserted-by":"crossref","unstructured":"Halada S, Casado-Medrano V, Baran JA, Lee J, Chinmay P, Bauer AJ, et al. Hormonal crosstalk between thyroid and breast cancer. Endocrinology. 2022;163(7):bqac075.","DOI":"10.1210\/endocr\/bqac075"},{"issue":"4","key":"16083_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1158\/1055-9965.EPI-18-0877","volume":"28","author":"EL Bolf","year":"2019","unstructured":"Bolf EL, Sprague BL, Carr FE. A linkage between thyroid and breast cancer: a common etiology. Cancer Epidemiol Biomarkers Prev. 2019;28(4):643\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"16083_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/21655979.2021.2012316","volume":"13","author":"W Xie","year":"2022","unstructured":"Xie W, Sun Y, Zeng Y, Hu L, Zhi J, Ling H, et al. Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer. Bioengineered. 2022;13(1):190\u2013205.","journal-title":"Bioengineered"},{"issue":"1","key":"16083_CR9","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1038\/s41467-023-40349-z","volume":"14","author":"D Bian","year":"2023","unstructured":"Bian D, Sun L, Hu J, Duan L, Xia H, Zhu X, et al. Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study. Nat Commun. 2023;14(1):4655.","journal-title":"Nat Commun"},{"key":"16083_CR10","doi-asserted-by":"publisher","first-page":"116866","DOI":"10.1016\/j.taap.2024.116866","volume":"484","author":"S Nazari","year":"2024","unstructured":"Nazari S, Mosaffa F, Poustforoosh A, Mortazavi M, Saso L, Firuzi O, et al. Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters. Toxicol Appl Pharmacol. 2024;484:116866.","journal-title":"Toxicol Appl Pharmacol"},{"key":"16083_CR11","doi-asserted-by":"crossref","unstructured":"Dong MZ, Ouyang YC, Gao SC, Ma XS, Hou Y, Schatten H, et al. PPP4C facilitates homologous recombination DNA repair by dephosphorylating PLK1 during early embryo development. Development. 2022;149(10):dev200351.","DOI":"10.1242\/dev.200351"},{"issue":"8","key":"16083_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/1541-7786.MCR-13-0032","volume":"11","author":"B Theobald","year":"2013","unstructured":"Theobald B, Bonness K, Musiyenko A, Andrews JF, Urban G, Huang X, et al. Suppression of Ser\/Thr phosphatase 4 (PP4C\/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death. Mol Cancer Res. 2013;11(8):845\u201355.","journal-title":"Mol Cancer Res"},{"issue":"17","key":"16083_CR13","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.4161\/cc.25919","volume":"12","author":"M Voss","year":"2013","unstructured":"Voss M, Campbell K, Saranzewa N, Campbell DG, Hastie CJ, Peggie MW, et al. Protein phosphatase 4 is phosphorylated and inactivated by Cdk in response to spindle toxins and interacts with \u03b3-tubulin. Cell Cycle. 2013;12(17):2876\u201387.","journal-title":"Cell Cycle"},{"issue":"10","key":"16083_CR14","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.biocel.2008.03.021","volume":"40","author":"C Martin-Granados","year":"2008","unstructured":"Martin-Granados C, Philp A, Oxenham SK, Prescott AR, Cohen PT. Depletion of protein phosphatase 4 in human cells reveals essential roles in centrosome maturation, cell migration and the regulation of Rho GTPases. Int J Biochem Cell Biol. 2008;40(10):2315\u201332.","journal-title":"Int J Biochem Cell Biol"},{"key":"16083_CR15","doi-asserted-by":"crossref","unstructured":"Raja R, Wu C, Bassoy EY, Rubino TE, Utagawa EC, Magtibay PM, et al. PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling. J Immunother Cancer. 2022;10(12):e005026.","DOI":"10.1136\/jitc-2022-005026"},{"issue":"1","key":"16083_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10238-024-01356-6","volume":"24","author":"X Hui","year":"2024","unstructured":"Hui X, Li L, Xiong W, Liu Y, Li H, Zhang H, et al. High PPP4C expression predicts poor prognosis in diffuse large B-cell lymphoma. Clin Exp Med. 2024;24(1):89.","journal-title":"Clin Exp Med"},{"key":"16083_CR17","doi-asserted-by":"crossref","unstructured":"Hang J, Lau SY, Yin R, Zhu L, Zhou S, Yuan X, et al. The role of phosphoprotein phosphatases catalytic subunit genes in pancreatic cancer. Biosci Rep. 2021;41(1):BSR20203282.","DOI":"10.1042\/BSR20203282"},{"key":"16083_CR18","doi-asserted-by":"publisher","first-page":"1416632","DOI":"10.3389\/fimmu.2024.1416632","volume":"15","author":"K Wang","year":"2024","unstructured":"Wang K, Peng B, Xu R, Lu T, Chang X, Shen Z, et al. Comprehensive analysis of PPP4C\u2019s impact on prognosis, immune microenvironment, and immunotherapy response in lung adenocarcinoma using single-cell sequencing and multi-omics. Front Immunol. 2024;15:1416632.","journal-title":"Front Immunol"},{"key":"16083_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1042\/bj3470845","volume":"347 Pt 3","author":"CJ Hastie","year":"2000","unstructured":"Hastie CJ, Carnegie GK, Morrice N, Cohen PT. A novel 50 kDa protein forms complexes with protein phosphatase 4 and is located at centrosomal microtubule organizing centres. Biochem J. 2000;347 Pt 3:845\u201355.","journal-title":"Biochem J"},{"issue":"5","key":"16083_CR20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.devcel.2012.03.001","volume":"22","author":"S Jia","year":"2012","unstructured":"Jia S, Dai F, Wu D, Lin X, Xing C, Xue Y, et al. Protein phosphatase 4 cooperates with Smads to promote BMP signaling in dorsoventral patterning of zebrafish embryos. Dev Cell. 2012;22(5):1065\u201378.","journal-title":"Dev Cell"},{"issue":"1","key":"16083_CR21","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1186\/s12967-025-07370-w","volume":"23","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wang W. Recent progress in immune evasion mechanisms of triple-negative breast cancer. J Transl Med. 2025;23(1):1314.","journal-title":"J Transl Med"},{"issue":"16","key":"16083_CR22","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.7150\/jca.44506","volume":"11","author":"H Yin","year":"2020","unstructured":"Yin H, Tang Y, Guo Y, Wen S. Immune microenvironment of thyroid cancer. J Cancer. 2020;11(16):4884\u201396.","journal-title":"J Cancer"},{"key":"16083_CR23","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"16083_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cytogfr.2016.02.001","volume":"31","author":"MG Ertosun","year":"2016","unstructured":"Ertosun MG, Hapil FZ, Osman Nidai O. E2F1 transcription factor and its impact on growth factor and cytokine signaling. Cytokine Growth Factor Rev. 2016;31:17\u201325.","journal-title":"Cytokine Growth Factor Rev"},{"key":"16083_CR25","doi-asserted-by":"publisher","first-page":"110423","DOI":"10.1016\/j.abb.2025.110423","volume":"769","author":"Y Jing","year":"2025","unstructured":"Jing Y, Zheng W, Zhou Z, Yao H, Zhang W, Wu Y, et al. Recent research advances of c-fos in regulating cell senescence. Arch Biochem Biophys. 2025;769:110423.","journal-title":"Arch Biochem Biophys"},{"issue":"3-4","key":"16083_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12672-020-00388-0","volume":"11","author":"DK Lung","year":"2020","unstructured":"Lung DK, Reese RM, Alarid ET. Intrinsic and extrinsic factors governing the transcriptional regulation of ESR1. Horm Cancer. 2020;11(3\u20134):129\u201347.","journal-title":"Horm Cancer"},{"key":"16083_CR27","doi-asserted-by":"crossref","unstructured":"\u00d6zturan D, Morova T, Lack NA. Androgen receptor-mediated transcription in prostate cancer. Cells. 2022;11(5):898.","DOI":"10.3390\/cells11050898"},{"issue":"5","key":"16083_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3892\/ol.2023.13762","volume":"25","author":"W Si","year":"2023","unstructured":"Si W, Kan C, Zhang L, Li F. Role of RUNX2 in breast cancer development and drug resistance (Review). Oncol Lett. 2023;25(5):176.","journal-title":"Oncol Lett"},{"issue":"3","key":"16083_CR29","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10549-012-2126-1","volume":"134","author":"M Schuler","year":"2012","unstructured":"Schuler M, Awada A, Harter P, Canon JL, Possinger K, Schmidt M, et al. A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer. Breast Cancer Res Treat. 2012;134(3):1149\u201359.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"16083_CR30","first-page":"188928","volume":"1878","author":"L Zhang","year":"2023","unstructured":"Zhang L, Feng Q, Wang J, Tan Z, Li Q, Ge M. Molecular basis and targeted therapy in thyroid cancer: progress and opportunities. Biochimica et Biophysica Acta (BBA). 2023;1878(4):188928.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"14","key":"16083_CR31","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1111\/j.1742-4658.2006.05336.x","volume":"273","author":"CJ Hastie","year":"2006","unstructured":"Hastie CJ, V\u00e1zquez-Martin C, Philp A, Stark MJ, Cohen PT. The Saccharomyces cerevisiae orthologue of the human protein phosphatase 4 core regulatory subunit R2 confers resistance to the anticancer drug cisplatin. FEBS J. 2006;273(14):3322\u201334.","journal-title":"FEBS J"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16083-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:07:04Z","timestamp":1782180424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16083-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16083"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16083-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Fujian Provincial Hospital (K2023-03\u2013016) and conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent. Tissue samples were anonymized before analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study used anonymized tissue samples without identifiable personal information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"768"}}